References
- Arvin AM. Varicella-zoster virus. Clin Microbiol Rev 1996;9:361–81
- Whitley RJ. Varicella-zoster virus infections. In: Galasso GJ, Whitley RJ, Merigan TC, editors. Antiviral agents and viral diseases of man. New York, NY: Raven Press; 1990. p 235-63
- Manfredi R, Chiodo F, Titone L, et al. Chickenpox complications among immunocompetent hospitalized children in Italy. Pediatr Med Chir 1997;19:99-104
- Ozdemir H, Candir MO, Karbuz A. Chickenpox complications, incidence and financial burden in previously healthy children and those with an underlying disease in Ankara in the pre-vaccination period. Turk J Pediatr 2011;53:614-25
- Bardach A, Cafferata ML, Klein K, et al. Incidence and use of resources for chickenpox and herpes zoster in Latin America and the Caribbean—a systematic review and meta-analysis. Pediatr Infect Dis J 2012;31:1263-8
- Heininger U, Seward JF. Varicella. Lancet 2006;68:1365-76
- Sadzot-Delvaux C, Rentier B, Wutzler P, et al. Varicella vaccination in Japan, South Korea, and Europe. J Infect Dis 2008;197(Suppl2):S185-S190
- Ministerio de Salud. Boletín integrado de vigilancia: Secretaría de Promoción y programas sanitarios (N° 296 - SE 5). Ministerio de Salud; 2016. República Argentina. Available from: http://www.msal.gob.ar/images/stories/boletines/Boletin-Integrado-De-Vigilancia-N296-SE5.pdf
- Dayan GH, Panero MS, Debbag R, et al. Varicella seroprevalence and molecular epidemiology of varicella-zoster virus in Argentina, 2002. J Clin Microbiol 2004;42:5698-704
- Ministerio de Salud. Estadisticas Vitales: Information Basica - ANO 2014 (Serie 5 - Número 58). Ministerio de Salud; 2015. Buenos Aires, República Argentina. http://deis.msal.gov.ar/wp-content/uploads/2016/01/Serie5Nro58.pdf
- Ministerio de Salud. Fundamentos de la introducción de la vacuna contra varicela al Calendario Nacional de Inmunizaciones 2015. Ministerio de Salud; 2014. Argentina. https://www.santafe.gov.ar/index.php/web/content/download/218645/1137054/file/Lineamientos%20varicela%202015.pdf
- Ministerio de Salud. Recomendaciones sobre control de la varicela para equipos de salud. Ministerio de Salud; 2011. República Argentina. http://www.msal.gob.ar/images/stories/epidemiologia/inmunizaciones/equipos-de-salud/recoemndaciones-varicela-es-2011.pdf
- Takahashi M, Okuno Y, Otsuka T, et al. Development of a live attenuated varicella vaccine. Biken J 1975;18:25-33
- Oh SH, Choi EH, Shin SH, et al. Varicella and varicella vaccination in South Korea. Clin Vaccine Immunol 2014;21:762-8
- White CJ, Kuter BJ, Hildebrand CS, et al. Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987 to 1989. Pediatrics 1991;87:604-10
- Just M, Berger R, Luescher D. Live varicella vaccine in healthy individuals. Postgrad Med J 1985;61(Suppl4):129-32
- Arbeter AM, Starr SE, Plotkin SA. Varicella vaccine studies in healthy children and adults. Pediatrics 1986;78:748-56
- Gatchalian S, Leboulleux D, Desauziers E, et al. Immunogenicity and safety of a varicella vaccine, Okavax, and a trivalent measles, mumps and rubella vaccine, MMR-II, administered concomitantly in healthy Filipino children aged 12–24 months. Southeast Asian J Trop Med Public Health 2003;34:589-97
- Knuf M, Habermehl P, Zepp F, et al. Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children. Pediatr Infect Dis J 2006;25:12-18
- Kuter BJ, Brown ML, Hartzel J, et al. Safety and immunogenicity of a combination measles, mumps, rubella and varicella vaccine (ProQuad). Hum Vaccin 2006;2:205-14
- Marin M, Marti M, Kambhampati A, et al. Global varicella vaccine effectiveness: a meta-analysis. Pediatrics 2016;137:e20153741
- World Health Organization. Varicella and herpes zoster vaccines: WHO position paper, June 2014. Weekly Epidemiological Record (WER) 2014;25:265-88
- World Health Organization. Systematic review of available evidence on effectiveness and duration of protection of varicella vaccines. WHO; 2014. Geneva. http://www.who.int/immunization/sage/meetings/2014/april/presentations_background_docs/en/
- Fu C, Wang M, Liang J, et al. The effectiveness of varicella vaccine in China. Pediatr Infect Dis J 2010;29:690-3
- Kurugol Z, Halicioglu O, Koc F, et al. Varicella rates among unvaccinated and one-dose vaccinated healthy children in Izmir, Turkey. Int J Infect Dis 2011;15:e475-80
- Huang WC, Huang LM, Chang IS, et al. Varicella breakthrough infection and vaccine effectiveness in Taiwan. Vaccine 2011;29:2756-60
- Hirose M, Gilio AE, Ferronato AE, et al. The impact of varicella vaccination on varicella-related hospitalization rates: global data review. Rev Paul Pediatr 2016;34:359-66
- Guris D, Jumaan AO, Mascola L, et al. Changing varicella epidemiology in active surveillance sites—United States, 1995–2005. J Infect Dis 2008;197(Suppl2):S71-S5
- Lopez AS, Zhang J, Marin M. Epidemiology of varicella during the 2-dose varicella vaccination program – United States, 2005–2014. MMWR Morb Mortal Wkly Rep 2016;65:902-5
- The International Society for Pharmacoepidemiology. Guidelines for good pharmacoepidemiology practices (GPP). ISP; 2015. Bethesda. https://www.pharmacoepi.org/resources/guidelines_08027.cfm
- Alfabeta.net. Manual Farmacéutico On Line; 2014 version. http://www.alfabeta.net/productos/mfonline-ar.jsp
- Alfabeta.net. Manual Farmacéutico On Line; 2016 version. http://www.alfabeta.net/productos/mfonline-ar.jsp
- Rojas G, Bartoloni L, Dillon C, et al. Clinical and economic characteristics associated with direct costs of Alzheimer’s, frontotemporal and vascular dementia in Argentina. Int Psychogeriatr 2011;23:554-61
- Embassy of the United States of America in Argentina. Instrucciones Para El Examen Medico. Embassy of the United States of America in Argentina; 2014. Buenos Aires, Argentina. http://photos.state.gov/libraries/48675/CONS-IV/Med%20Exam%20Instructions%20_1014_.pdf
- International Federation of Health Plans. Comparative price report: medical and hospital fees by country. International Federation of Health Plans; 2011. London, UK. http://www.indiana.edu/∼uhrs/UFCBC/pubs/2011iFHPPriceReportGraphs_version3.pdf
- International Federation of Health Plans. Comparative price report: variation in medical and hospital prices by country. International Federation of Health Plans; 2012. London, UK. http://hushp.harvard.edu/sites/default/files/downloadable_files/IFHP%202012%20Comparative%20Price%20Report.pdf
- No author. Cuánto cuesta una consulta a un especialista. Minuto Uno [newpaper on the internet]; 2012. https://www.minutouno.com/notas/260223-cuanto-cuesta-una-consulta-un-especialista
- Raggio J. Cuánto se paga hoy una sesión de terapia. La Nacion [Newspaper on the internet]; 2012. http://www.lanacion.com.ar/1497761-cuanto-se-paga-hoy-una-sesion-de-terapia
- Gobierno de la Ciudad Autónoma de Buenos Aires, Ministero de Salud. Nomenclador de Prestaciones de Salud. 2014. Buenos Aires. http://www.buenosaires.gob.ar/salud/sigehos
- Confederacion Unoficada Bioquima de la republica Argentina. Nomenclador Bioqumico Unico (NBU). PMO y Practicas Especiales; 2012. República Argentina.
- Gentile A, Salgueiro AL, García Bournissen F, et al. Cost of Bordetella pertussis illness in tertiary hospitals in Argentina. Arch Argent Pediatr 2013;111:295-302
- International Federation of Health Plans. Comparative price report: variation in medical and hospital prices by country. IFHP; 2013. London, UK. http://static.squarespace.com/static/518a3cfee4b0a77d03a62c98/t/534fc9ebe4b05a88e5fbab70/1397737963288/2013%20iFHP%20FINAL%204%2014%2014.pdf
- Miravitlles M, Jardim JR, Zitto T, et al. [Pharmacoeconomic study of antibiotic therapy for exacerbations of chronic bronchitis and chronic obstructive pulmonary disease in Latin America]. Arch Bronconeumol 2003;39:549-53
- Rosenthal VD, Guzman S, Migone O, et al. The attributable cost and length of hospital stay because of nosocomial pneumonia in intensive care units in 3 hospitals in Argentina: a prospective, matched analysis. Am J Infect Control 2005;33:157-61
- The World Bank. Inflation, GDP deflator (annual %). 2015. Argentina. http://data.worldbank.org/indicator/NY.GDP.DEFL.KD.ZG?end=2016&locations=AR-CA&start =1961&view=chart
- OECD.stat. 2015. https://stats.oecd.org/
- Valentim J, Sartori AM, de Soárez PC, et al. Cost-effectiveness analysis of universal childhood vaccination against varicella in Brazil. Vaccine 2008;26:6281-91
- de Campos C, Romao M, Ferraz A, et al. Hospitalizations by the Brazilian Health System due to traffic accidents. XVIII Congreso Panamericano de Ingeniería de Tránsito, Transporte y Logística (PANAM 2014). Procedia – Social and Behavioral Sciences 2014;162:282-9
- Morínigo S, Chiarelli G, Corallo T, et al. Hospitalizaciones por varicela. Abstract RPD 84. Presented at 7° Congreso Argentino de Infectología Pediátrica, 1° jornadas de enfermería en infectología Pediátrica; 2014
- OECD. OECD Data. Exchange Rates, Argentina. OECD; 2015. https://data.oecd.org/conversion/exchange-rates.htm
- Fornaro P, Gandini F, Marin M, et al. Epidemiology and cost analysis of varicella in Italy: results of a sentinel study in the pediatric practice. Pediatr Infect Dis J 1999;18:414-19
- Iseli A, Aebi C, Banz K, et al. Prospective surveillance of varicella-zoster virus infections in an out-patient setting in Switzerland. Hum Vaccin 2009;5:843-6
- Wagenpfeil S, Neiss A, Banz K, et al. Empirical data on the varicella situation in Germany for vaccination decisions. Clin Microbiol Infect 2004;10:425-30
- Blumental S, Sabbe M, Lepage P, et al. Varicella paediatric hospitalisations in Belgium: a 1-year national survey. Arch Dis Child 2016;101:16-22
- Liese JG, Grote V, Rosenfeld E, et al. The burden of varicella complications before the introduction of routine varicella vaccination in Germany. Pediatr Infect Dis J 2008;27:119-24
- Turel O, Bakir M, et al. Children hospitalized for Varicella: complications and cost burden. ViHRI 2013;2:226-30
- Peuchot A, Peuchot J, Corazza R, et al. Hospitalizaciones por complicaciones en varicela. Abstract RPD 6: presented at 7° Congreso Argentino de Infectología Pediátrica, 1° jornadas de enfermería en infectología Pediátrica. Ciudad de Córdoba, Provincia de Córdoba, Argentina. April 3–5, 2014
- Melonari P, Rodriguez Saá C, Olguín M, et al. Complicaciones y costos por varicela en ninos de un hospital pediatrico de Argentina. Abstract PO 166: presented at 7° Congreso Argentino de Infectología Pediátrica, 1° jornadas de enfermería en infectología Pediátrica. Ciudad de Córdoba, Provincia de Córdoba, Argentina. April 3–5, 2014.
- Mallet E, Maitre M, Delalande-Dutilleul L, et al. [Evaluation of varicella complications through a retrospective hospital survey in a paediatric center over 16 years in France]. Arch Pediatr 2004;11:1145-51
- Marchetto S, de Benedictis FM, de Martino M, et al. Epidemiology of hospital admissions for chickenpox in children: an Italian multicentre study in the pre-vaccine era. Acta Paediatr 2007;96:1490-3
- Bonhoeffer J, Baer G, Muehleisen B, et al. Prospective surveillance of hospitalisations associated with varicella-zoster virus infections in children and adolescents. Eur J Pediatr 2005;164:366-70
- Brisson M, Edmunds WJ. Epidemiology of varicella-zoster virus in England and Wales. J Med Virol 2003;70(Suppl1):S9-S14
- Law B, Fitzsimon C, Ford-Jones L, The Immunization Monitoring Program-Active (IMPACT). et al. Cost of chickenpox in Canada: part II. Cost of complicated cases and total economic impact. Pediatrics 1999;104:7-14
- OANDA Corporation; 2016. https://www.oanda.com/currency/average
- United States Department of Labor. Bureau of Labor Statistics Data Tools. US DoL; 2016. Washington, DC, United States. http://data.bls.gov/pdq/SurveyOutputServlet
- Zhou F, Shefer A, Wenger J, et al. Economic evaluation of the routine childhood immunization program in the United States, 2009. Pediatrics 2014;133:577-85
- Quian J, Rüttimann R, Romero C, et al. Impact of universal varicella vaccination on 1-year-olds in Uruguay: 1997–2005. Arch Dis Child 2008;93:845-50
- Paternina-Caicedo A, De la Hoz-Restrepo F, Gamboa-Garay O, et al. How cost effective is universal varicella vaccination in developing countries? A case-study from Colombia. Vaccine 2013;31:402-9